178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy
| Główni autorzy: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artykuł |
| Język: | English |
| Wydane: |
BMJ Publishing Group
2023-11-01
|
| Seria: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1827763168835796992 |
|---|---|
| author | Li Liu Simon Turcotte Shari Pilon-Thomas Doris Wiener Brian Czerniecki Matthew Beatty Larissa Pikor Urminder Singh Christian E Laing Jacob Gibson Anna Kluew Mahdi Golkaram Sven Bilke Nathalie Brassard Stewart E Abbot Timothy J Langer Grace DeSantis Michael J Ciancanelli Jeff H Tsai |
| author_facet | Li Liu Simon Turcotte Shari Pilon-Thomas Doris Wiener Brian Czerniecki Matthew Beatty Larissa Pikor Urminder Singh Christian E Laing Jacob Gibson Anna Kluew Mahdi Golkaram Sven Bilke Nathalie Brassard Stewart E Abbot Timothy J Langer Grace DeSantis Michael J Ciancanelli Jeff H Tsai |
| author_sort | Li Liu |
| collection | DOAJ |
| first_indexed | 2024-03-11T10:48:22Z |
| format | Article |
| id | doaj.art-bfb51f7b4be743b8afa4dc27c2b7dc03 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T10:48:22Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-bfb51f7b4be743b8afa4dc27c2b7dc032023-11-13T22:00:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0178178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapyLi Liu0Simon Turcotte1Shari Pilon-Thomas2Doris Wiener3Brian Czerniecki4Matthew Beatty5Larissa Pikor6Urminder Singh7Christian E Laing8Jacob Gibson9Anna Kluew10Mahdi Golkaram11Sven Bilke12Nathalie Brassard13Stewart E Abbot14Timothy J Langer15Grace DeSantis16Michael J Ciancanelli17Jeff H Tsai181Illumina, San Diego, CA, USA4Université de Montréal, Montreal, QC, Canada6H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA5Moffitt Cancer Center, Tampa, FL, USA5Moffitt Cancer Center, Tampa, FL, USA5Moffitt Cancer Center, Tampa, FL, USATurnstone Biologics, San Diego, CA, USA1Illumina, San Diego, CA, USA2Turnstone Biologics, Carlsbad, CA, USA1Illumina, San Diego, CA, USA3Turnstone Biologics, San Diego, CA, USA1Illumina, San Diego, CA, USA1Illumina, San Diego, CA, USA4Université de Montréal, Montreal, QC, Canada3Turnstone Biologics, San Diego, CA, USA3Turnstone Biologics, San Diego, CA, USA1Illumina, San Diego, CA, USA3Turnstone Biologics, San Diego, CA, USA1Illumina, San Diego, CA, USA |
| spellingShingle | Li Liu Simon Turcotte Shari Pilon-Thomas Doris Wiener Brian Czerniecki Matthew Beatty Larissa Pikor Urminder Singh Christian E Laing Jacob Gibson Anna Kluew Mahdi Golkaram Sven Bilke Nathalie Brassard Stewart E Abbot Timothy J Langer Grace DeSantis Michael J Ciancanelli Jeff H Tsai 178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy Journal for ImmunoTherapy of Cancer |
| title | 178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy |
| title_full | 178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy |
| title_fullStr | 178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy |
| title_full_unstemmed | 178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy |
| title_short | 178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy |
| title_sort | 178 tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor infiltrating lymphocyte therapy |
| work_keys_str_mv | AT liliu 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT simonturcotte 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT sharipilonthomas 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT doriswiener 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT brianczerniecki 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT matthewbeatty 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT larissapikor 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT urmindersingh 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT christianelaing 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT jacobgibson 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT annakluew 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT mahdigolkaram 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT svenbilke 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT nathaliebrassard 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT stewarteabbot 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT timothyjlanger 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT gracedesantis 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT michaeljciancanelli 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy AT jeffhtsai 178tumorneoantigenprioritizationfromliquidbiopsywholeexomesequencingforselectedtumorinfiltratinglymphocytetherapy |